Marshall Wace, LLP Absci Corp Transaction History

Marshall Wace, LLP

$81.7 Billion
Q2 2025

A detailed history of Marshall Wace, LLP transactions in Absci Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 612,878 shares of ABSI stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

612,878

Holding current value

$1.82 Million

% of portfolio

0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$2.24 - $3.22 $1.37 Million - $1.97 Million	612,878 New	612,878 $1.58 Million
Q4 2024 Feb 13, 2025	SELL	$2.55 - $4.38 $389,933 - $669,767	-152,915 Reduced 11.72%	1,151,846 $3.02 Million
Q3 2024 Nov 14, 2024	SELL	$2.97 - $4.49 $1.57 Million - $2.38 Million	-529,141 Reduced 28.85%	1,304,761 $4.98 Million
Q2 2024 Aug 14, 2024	BUY	$2.92 - $6.58 $1.01 Million - $2.28 Million	347,079 Added 23.34%	1,833,902 $5.65 Million
Q1 2024 May 15, 2024	BUY	$3.41 - $5.74 $4.27 Million - $7.19 Million	1,252,881 Added 535.55%	1,486,823 $8.45 Million
Q4 2023 Feb 14, 2024	BUY	$1.15 - $4.79 $140,923 - $586,976	122,542 Added 110.0%	233,942 $982,000
Q3 2023 Nov 14, 2023	BUY	$1.28 - $2.41 $142,592 - $268,474	111,400 New	111,400 $147,000

Others Institutions Holding ABSI

# of Institutions

142

Shares Held

68.9M

Call Options Held

469K

Put Options Held

547K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

10M
Shares

$29.8 Million
0.21% of portfolio
Redmile Group, LLC San Francisco, CA

8.25M
Shares

$24.5 Million
2.58% of portfolio
Vanguard Group Inc Valley Forge, PA

6.45M
Shares

$19.2 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.34M
Shares

$15.9 Million
0.0% of portfolio
Fred Alger Management, LLC New York, NY

3.93M
Shares

$11.7 Million
0.05% of portfolio

View Full List

About Absci Corp

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $276M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

More about ABSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account